The Print on MSN
Why do women make up two-thirds of Alzheimer’s cases? Study links risk to hormonal changes in midlife
New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than ...
Scientists reverse Alzheimer's memory loss in mice by using NAD+ to restore brain energy, defying decades of research.
GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic kidney disease in type 2 diabetes, obesity-related heart failure, knee ...
Older people with a genetic risk of Alzheimer's disease did not experience the expected increase in cognitive decline and dementia risk if they consumed relatively large amounts of meat.
News Medical on MSN
Machine learning detects early brain changes linked to Alzheimer's disease
Worcester Polytechnic Institute (WPI) researchers have used a form of artificial intelligence (AI) to analyze anatomical changes in the brain and predict Alzheimer's disease with nearly 93% accuracy.
The first study to evaluate the link between Alzheimer’s disease and body weight found a significant association. Researchers at Washington University Medicine in St. Louis, Missouri, discovered that ...
Amyloid beta and tau proteins compete for the same binding sites on microtubules in neurons, suggesting that displacement of ...
A study in the journal Neurology has shown that people with type 1 diabetes are three times more likely to develop dementia ...
Biomed Industries, Inc. Presented Breakthrough Unified Theory Linking Alzheimer’s Disease, Obesity and Cardiovascular ...
Hosted on MSN
Obesity risk: Being overweight can double your chances of getting dementia, warns new study
If you're worried about your weight, here's another big reason to pay attention. A new study has found that being obese can actually double your risk of developing dementia later in life. The research ...
POTOMAC, MD / ACCESS Newswire / March 18, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing therapeutics for Alzheimer's disease, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results